![]() |
市場調查報告書
商品編碼
1547534
全球口腔薄膜市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測Global Oral Thin Films Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球口腔薄膜市場需求預計將從 2023 年的 39.9 億美元增至 2032 年的近 92.9 億美元,2024-2032 年研究期間複合年成長率為 9.85%。
口腔薄膜是用於藥物傳遞的薄而柔韌的薄膜,可溶解在口腔黏膜中,從而快速起效並增強藥物的生物利用度。口服薄膜劑主要用於不能服用固體形式藥物的老年、兒童和臥床患者。因此,製藥公司正大力研發將現有藥物轉為速溶口服薄膜藥物。此外,口腔薄膜的應用不僅限於口腔系統,也擴展到胃滯留和舌下給藥系統的應用。因此,製藥業正致力於縮短藥物開發時間和高效的藥物傳輸平台。此外,對高效藥物傳輸技術和藥物運輸便利性的需求不斷成長,這在最近推動了市場的發展。
口腔膜劑由親水性聚合物組成,在舌頭或口腔中快速溶解,與液體接觸時透過溶解將藥物輸送到體循環。口服薄膜有幾個優點:起效快、易於運輸、繞過肝臟首過效應和易於操作。此外,它們還具有較高的生物利用度和藥物的快速吸收。因此,舌下口腔薄膜是片劑的更好替代品,因為它提供完整的藥物傳遞以快速緩解症狀。此外,吞嚥困難的人需要口服藥物。因此,為了快速口服藥物而開發了口服薄膜藥物。為了提高患者的依從性,市場參與者開發了各種類型的疫苗和荷爾蒙。使用口腔薄膜來防止酸敏感藥物胃腸道分解將推動全球市場。然而,口腔薄膜治療的昂貴成本、大量研究投資的需求以及與藥物開發相關的挑戰正在阻礙全球市場的成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球口腔薄膜市場的各個細分市場進行了包容性評估。口腔薄膜產業的成長和趨勢為本研究提供了整體方法。
口腔薄膜市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲口腔薄膜市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。口腔薄膜市場的主要參與者包括Aquestive Therapeutics Inc.、CL Pharm、Cure Pharmaceutical、Dr. Reddy'S Laboratories、Indivior Plc、IntelGenx Corp.、Kyu Kyu Pharmaceutical Co. Ltd.、DK Livkon Pvt.。有限公司、NAL Pharma、Seoul Pharma Co. Ltd.、Shilpa Therapeutics Pvt. Ltd.有限公司、Sunovion Pharmaceuticals Inc.、以星實驗室有限公司。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Oral Thin Films Market is presumed to reach the market size of nearly USD 9.29 Billion by 2032 from USD 3.99 Billion in 2023 with a CAGR of 9.85% under the study period 2024-2032.
Oral thin films are thin, flexible films used for drug delivery that dissolve in the oral mucosa resulting in the rapid onset of action and enhanced bioavailability for drugs. The oral thin films are mainly used for geriatric, pediatric, and bedridden patients who cannot intake the solid form of the medicine. Therefore, the pharmaceutical companies are carrying out remarkable R&D to switch their existing drugs in the fast dissolving oral thin films drugs. Moreover, the application of oral thin films is not limited to buccal systems but also expands in the applications of gastroretentive and sublingual delivery systems. Therefore, the pharmaceutical industry is concentrating on shortening drug development timelines and efficient drug delivery platforms. Moreover, there is a growing demand for efficient drug delivery techniques and convenience in the transportation of the drug, which has fuelled the market in the recent past.
The oral film is made up of hydrophilic polymers that quickly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. Oral thin films have several advantages: the fast onset of action, ease of transportation, bypassing hepatic first-pass effect, and handling. In addition, these offer high bioavailability and rapid absorption for drugs. Therefore, the sublingual oral thin film is a better alternative for tablets, as it provides complete drug delivery for quick relief. Besides, people with swallowing difficulty require oral administration of drugs. Therefore, oral thin film medication is developed for swift oral administration of medicines. To improve patient compliance, various types of vaccines and hormones are developed by the market players. The use of oral thin films for preventing gastrointestinal degradation of acid-sensitive drugs will drive the global market. However, the expensive cost of treatments involving oral thin films, the requirement of vast research investment, and challenges related to drug development are hampering the market growth at the global level.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oral Thin Films. The growth and trends of Oral Thin Films industry provide a holistic approach to this study.
This section of the Oral Thin Films market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Oral Thin Films market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oral Thin Films market include Aquestive Therapeutics Inc., C.L. Pharm, Cure Pharmaceutical, Dr. Reddy'S Laboratories, Indivior Plc, IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., DK Livkon Pvt. Ltd., NAL Pharma, Seoul Pharma Co. Ltd., Shilpa Therapeutics Pvt. Ltd., Sunovion Pharmaceuticals Inc., ZIM Laboratories Limited. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.